Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
anti-ctla-4/pd-1 expressing egfr-car-t cells (1 trial)
anti-ctla-4/pd-1 expressing muc1-car-t cells (1 trial)
dendritic cells (3 trials)
herincar-pd1 cells (1 trial)
mesothelin car t cells (1 trial)
pd-1 antibody expressing mesocar-t cells (1 trial)
autologous tumor infiltrating lymphocytes (1 trial)
pd1-til (1 trial)
Glioblastoma (Phase 1)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Neoplasms (Phase 2)
Stomach Neoplasms (Phase 2)
Trials (9 total)
Trial APIs (8 total)